Compile Data Set for Download or QSAR
maximum 50k data
Found 28 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 6943
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50334454(CHEMBL1643895 | Ramosetron | US9045501, Ramosetron)
Affinity DataKi:  0.0600nM ΔG°:  -58.3kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014549(CHEMBL3261480 | US9045501, 4)
Affinity DataKi:  0.200nM ΔG°:  -55.4kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014558(ALOSETRON | CHEBI:253342 | Lotronex | US9045501, A...)
Affinity DataKi:  0.5nM ΔG°:  -53.1kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank

Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014552(CHEMBL3261483 | US9045501, 8)
Affinity DataKi:  0.5nM ΔG°:  -53.1kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160716(US9045501, 11)
Affinity DataKi:  0.800nM ΔG°:  -51.9kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160732(US9045501, 29)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160717(US9045501, 12)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014548(CHEMBL3261479 | US9045501, 2)
Affinity DataKi:  4nM ΔG°:  -47.9kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160711(US9045501, 3)
Affinity DataKi:  5nM ΔG°:  -47.4kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160714(US9045501, 9)
Affinity DataKi:  6nM ΔG°:  -46.9kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014556(CHEMBL3261486 | US9045501, 25)
Affinity DataKi:  7nM ΔG°:  -46.5kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014550(CHEMBL3261481 | US9045501, 7)
Affinity DataKi:  8nM ΔG°:  -46.2kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160730(US9045501, 27)
Affinity DataKi:  8nM ΔG°:  -46.2kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160715(US9045501, 10)
Affinity DataKi:  14nM ΔG°:  -44.8kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160733(US9045501, 30 (Enant. A) | US9045501, 31 (Enant. B...)
Affinity DataKi:  24nM ΔG°:  -43.5kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160731(US9045501, 28)
Affinity DataKi:  30nM ΔG°:  -42.9kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160718(US9045501, 13)
Affinity DataKi:  32nM ΔG°:  -42.8kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160734(US9045501, 32)
Affinity DataKi:  73nM ΔG°:  -40.7kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014547(CHEMBL3261478 | US9045501, 1)
Affinity DataKi:  74nM ΔG°:  -40.7kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160722(US9045501, 17)
Affinity DataKi:  130nM ΔG°:  -39.3kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160713(US9045501, 6)
Affinity DataKi:  205nM ΔG°:  -38.2kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160728(US9045501, 23)
Affinity DataKi:  206nM ΔG°:  -38.2kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160733(US9045501, 30 (Enant. A) | US9045501, 31 (Enant. B...)
Affinity DataKi:  217nM ΔG°:  -38.0kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160735(US9045501, 33 (Enant. A) | US9045501, 34 (Enant. B...)
Affinity DataKi:  241nM ΔG°:  -37.8kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160726(US9045501, 21)
Affinity DataKi:  406nM ΔG°:  -36.5kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160712(US9045501, 5)
Affinity DataKi:  416nM ΔG°:  -36.4kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM160735(US9045501, 33 (Enant. A) | US9045501, 34 (Enant. B...)
Affinity DataKi:  579nM ΔG°:  -35.6kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target5-hydroxytryptamine receptor 3A(Homo sapiens (Human))
Albany Molecular Research

US Patent
LigandPNGBDBM50014557(CHEMBL3261487 | US9045501, 26)
Affinity DataKi:  701nM ΔG°:  -35.1kJ/molepH: 7.5 T: 2°CAssay Description:The relative affinity of the various compounds for the human 5-HT3 receptor was measured in a radioligand binding assay, using a scintillation proxim...More data for this Ligand-Target Pair
In DepthDetails US Patent